Cargando…

Letter to the editor UC-II® Undenatured type II collagen: update to analytical methods

Supplementation with UC-II® undenatured type II collagen has been shown to provide joint health benefits for both healthy adults and adults with knee osteoarthritis in controlled clinical trials. These trials used UC-II® materials with undenatured type II collagen characterized by an ELISA method th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lugo, James P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636149/ https://www.ncbi.nlm.nih.gov/pubmed/31311550 http://dx.doi.org/10.1186/s12970-019-0298-3

Ejemplares similares

Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers
por: Lugo, James P, et al.
Publicado: (2013)

Undenatured Type II Collagen (UC-II) in Joint Health and Disease: A Review on the Current Knowledge of Companion Animals
por: Gencoglu, Hasan, et al.
Publicado: (2020)

Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs
por: Stabile, Marzia, et al.
Publicado: (2019)

UC-II® undenatured type II collagen data show retention during functional food and beverage prototype processing
por: Pates, George, et al.
Publicado: (2023)

Long-term supplementation with an undenatured type-II collagen (UC-II(®)) formulation in dogs with degenerative joint disease: Exploratory study
por: Cabezas, Miguel Ángel, et al.
Publicado: (2022)

UNDENATURED COLLAGEN TYPE II FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
por: SADIGURSKY, DAVID, et al.
Publicado: (2022)

UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study
por: Schön, Christiane, et al.
Publicado: (2022)

Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
por: Crowley, David C., et al.
Publicado: (2009)

Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study
por: Lugo, James P., et al.
Publicado: (2016)

Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis
por: Sahin, Kazim, et al.
Publicado: (2021)

Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis
por: Orhan, Cemal, et al.
Publicado: (2021)

Undenatured type II collagen mitigates inflammation and cartilage degeneration in healthy Labrador Retrievers during an exercise regimen
por: Varney, J L, et al.
Publicado: (2021)

Impact of supplemented undenatured type II collagen on pain and mobility in healthy Labrador Retrievers during an exercise regimen
por: Varney, Jessica L, et al.
Publicado: (2022)

The effect of oral administration of undenatured type II collagen on monosodium iodoacetate-induced osteoarthritis in young and old rats
por: Sahin, Emre, et al.
Publicado: (2023)

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis”
por: Zhu, Qingcheng, et al.
Publicado: (2022)

Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata
por: Zapata, Ana, et al.
Publicado: (2023)

Letter to the Editor – Update from Ukraine: Rehabilitation and Research
por: Malakhov, Kyrylo S.
Publicado: (2022)

Letter to the Editor
por: Frisbie, James H.
Publicado: (2011)

Letter to the Editor
por: Lubowitz, James H.
Publicado: (2011)

Letter to the Editor: An Updated Overview of Low Back Pain Management
por: Maher, Christopher G., et al.
Publicado: (2022)

Letter to the editor
por: van Luijt, P. A., et al.
Publicado: (2012)

Letter to the editor for “Update of the human and mouse Fanconi anemia genes”
por: Nebert, Daniel W., et al.
Publicado: (2016)

Letter to the Editor: An Updated Overview of Low Back Pain Management
por: Vaish, Hina, et al.
Publicado: (2022)

Letter to Editor
por: Haghnegahdar, AA, et al.
Publicado: (2013)

Letters to the Editor
por: Barritt, D. W., et al.
Publicado: (1987)

Letter to the Editor
por: Koninckx, P.R., et al.
Publicado: (2023)

Letter to the Editor
por: Fox, P.R., et al.
Publicado: (2017)

Letter to the Editor
por: Monteiro‐Steagall, Beatriz P., et al.
Publicado: (2014)

Letter to the Editor: Type IV Is Not Type IV
por: Bauer, Thomas W.
Publicado: (2022)

Effects of Exercise Combined with Undenatured Type II Collagen on Endurance Capacity, Antioxidant Status, Muscle Lipogenic Genes and E3 Ubiquitin Ligases in Rats
por: Orhan, Cemal, et al.
Publicado: (2021)

Letter to the Editor on ‘Smoking cessation in pregnancy: An update for maternity care practitioners’
por: Braillon, Alain
Publicado: (2020)

Response to letter to the editor Re: Case report CT of rhabdomyolysis as a sequela of drug abuse
por: Weisberg, Edmund, et al.
Publicado: (2022)

LETTERS TO THE EDITOR
Publicado: (1974)

LETTERS TO THE EDITOR
por: Schurr, J. Michael
Publicado: (1964)

Letter to the Editor
por: Zavras, A, et al.
Publicado: (2005)

LETTERS TO THE EDITOR
por: Marro, F., et al.
Publicado: (1966)

Letters to the Editor
Publicado: (2012)

Letter to the Editor
por: Rahmati-holasoo, H, et al.
Publicado: (2011)

Letter to the editor
por: Bertolaccini, Luca, et al.
Publicado: (2010)

Letters to the Editor
por: Molnár, Bela G.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_go007sl6jnj1088dunrnjtidt7